Director, HEOR & RWE, Europe
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Director, HEOR & RWE, Europe will take part in the development of the strategy and execution across health economics and outcomes research (HEOR) and real-world evidence (RWE) to optimize the value demonstration of Revolution Medicines oncology portfolio across European markets. They will work closely with the rest of the European Medical Affairs Team, Global HEOR, and local affiliates to deliver an Integrated Evidence Plan that meets the regional and local needs for each asset and disease area. The role w
